Indicator | Eligible patients (n) | Performance (%) | ||||
---|---|---|---|---|---|---|
Total | Mean per service | Range across services | Mean (SD) | Range across services | ||
Eligible patients: the total number of eligible patients is different for each indicator. All patients were eligible for indicators 4 and 6 as it is the prevalence of these prescribing practices in the whole population that is of interest. For all other indicators, only the patients who were prescribed specific drugs were included as it is how these drugs are used that is of interest. | ||||||
Performance: for indicators 1–6, 0% would be ideal practice. The mean performance and range scores therefore quantify apparently suboptimal practice. The interpretation of indicator 7 is more complex and is discussed in the text. | ||||||
1 | High dose antipsychotics | 3559 | 73 | 19–203 | 22 (11) | 0–55 |
2 | Antipsychotic polypharmacy | 3559 | 73 | 19–203 | 47 (10) | 19–64 |
3 | Atypical polypharmacy | 1148 | 23 | 2–84 | 50 (33) | 0–100 |
4 | Multiple PRN | 4192 | 86 | 22–221 | 11 (8) | 0–41 |
5 | Low dose mood stabilisers | 615 | 13 | 2–32 | 48 (18) | 0–100 |
6 | Hypnotic prescribing | 4192 | 86 | 22–221 | 27 (17) | 4–68 |
7 | Benzodiazepines:antidepressants | 3072 | 63 | 18–151 | 1.2 (0.6) | 0.1–3.4 |